China Universal Asset Management »

Inhibrx shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Inhibrx (INBX) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Inhibrx

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $208k 5.5k 38.02
2023-09-30 $20k 1.1k 17.91
2023-06-30 $15k 572 26.22
2023-03-31 $11k 590 18.64
2022-12-31 $11k 442 24.89
2022-09-30 $7.0k 365 19.18

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Vertex Pharmaceuticals Common Stock (VRTX)
Adobe Common Stock (ADBE)
Nvidia Corp Common Stock (NVDA)
Meta Platforms Inc-class A Common Stock (META)
Servicenow Common Stock (NOW)
Amgen Common Stock (AMGN)
Regeneron Pharmaceuticals Common Stock (REGN)
Gilead Sciences Common Stock (GILD)
Tesla Common Stock (TSLA)
Visa Inc-class A Shares Common Stock (V)
Workday Inc-class A Common Stock (WDAY)
Alphabet Inc-cl A Common Stock (GOOGL)
Salesforce Common Stock (CRM)

View all positions for China Universal Asset Management

Top funds holding Inhibrx

Viking Global Investors
RA Capital Management
Perceptive Advisors
Vanguard Group
Arrowpoint Asset Management
Bank of America Corporation
Logos Global Management
Partner Fund Management
Russell Investments
Citadel Advisors
Caption Management
Millennium Management
Charles Schwab Investment Management
Sphera Funds Management
Two Sigma Advisers

View all funds holding Inhibrx